CMM-204: Prolotherapy

Prolotherapy (CPT/HCPCS M0076) is considered experimental, investigational, or unproven for treatment of musculoskeletal pain and/or instability (e.g., laxity, weakness) and is thus not covered. No specific documentation requirements or covered indications are provided, and final reimbursement determinations rest with the individual health plan.

"Based on the lack of conclusive scientific evidence demonstrating the clinical efficacy of prolotherapy combined with the potential to expose individuals to adverse side effects or complications, t..."

Sign up to see full coverage criteria, indications, and limitations.